Company Filing History:
2 out of 932 
1 out of 832,891 Years Active: 1995-2002
Title: David P Speert: Innovator in Mucus Clearance Technologies
Introduction
David P Speert is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of medical science, particularly in improving mucus clearance for patients with respiratory conditions. With a total of 3 patents, his work has the potential to enhance the quality of life for many individuals suffering from chronic respiratory diseases.
Latest Patents
One of Speert's latest patents focuses on the "Use of dextran and other polysaccharides to improve mucus clearance." This invention demonstrates how polysaccharides, such as dextran, can reduce viscoelasticity and enhance the clearability of mucus in cystic fibrosis patients. The findings indicate that dextran also reduces the viscoelasticity of healthy dog mucus, suggesting broader applications for improving mucus clearance in various conditions, including chronic bronchitis, bronchiectasis, and bronchial asthma.
Another significant patent is the "Method of preventing or reducing the risk of infection by bacterial pathogens." This method aims to reduce the risk of P. aeruginosa infection in compromised hosts, such as cystic fibrosis patients. The use of dextran or dextran sulfate as the active ingredient is central to this innovative approach.
Career Highlights
David P Speert has had a distinguished career, working at the University of British Columbia, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of mucus clearance and its implications for respiratory health.
Collaborations
Throughout his career, Speert has collaborated with esteemed colleagues, including Malcolm King and Thomas C Usher. These partnerships have fostered a collaborative environment that has led to significant advancements in medical research.
Conclusion
David P Speert's innovative work in the field of mucus clearance technologies showcases his dedication to improving patient outcomes. His patents reflect a commitment to addressing critical health challenges faced by individuals with respiratory conditions.